190 related articles for article (PubMed ID: 31849981)
1. CD4
Yamashita Y; Oe T; Kawakami K; Osada-Oka M; Ozeki Y; Terahara K; Yasuda I; Edwards T; Tanaka T; Tsunetsugu-Yokota Y; Matsumoto S; Ariyoshi K
Front Immunol; 2019; 10():2807. PubMed ID: 31849981
[No Abstract] [Full Text] [Related]
2. Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens.
Yamashita Y; Hoshino Y; Oka M; Matsumoto S; Ariga H; Nagai H; Makino M; Ariyoshi K; Tsunetsugu-Yokota Y
Jpn J Infect Dis; 2013; 66(3):207-15. PubMed ID: 23698481
[TBL] [Abstract][Full Text] [Related]
3. Enhanced IFN-γ, but not IL-2, response to Mycobacterium tuberculosis antigens in HIV/latent TB co-infected patients on long-term HAART.
Desalegn G; Tsegaye A; Gebreegziabiher D; Aseffa A; Howe R
BMC Immunol; 2019 Oct; 20(1):35. PubMed ID: 31601184
[TBL] [Abstract][Full Text] [Related]
4. Measurement of phenotype and absolute number of circulating heparin-binding hemagglutinin, ESAT-6 and CFP-10, and purified protein derivative antigen-specific CD4 T cells can discriminate active from latent tuberculosis infection.
Hutchinson P; Barkham TM; Tang W; Kemeny DM; Chee CB; Wang YT
Clin Vaccine Immunol; 2015 Feb; 22(2):200-12. PubMed ID: 25520147
[TBL] [Abstract][Full Text] [Related]
5.
Li J; Shen J; Lao S; Li X; Liu J; Wu C
Clin Sci (Lond); 2017 Aug; 131(15):1859-1876. PubMed ID: 28588103
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cytokine profiles related to
Yasuda I; Saludar NRD; Sayo AR; Suzuki S; Yokoyama A; Ozeki Y; Kobayashi H; Nishiyama A; Matsumoto S; Cox SE; Tanaka T; Yamashita Y
Front Immunol; 2024; 15():1330796. PubMed ID: 38665909
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
[TBL] [Abstract][Full Text] [Related]
8. ESAT-6- and CFP-10-specific Th1, Th22 and Th17 cells in tuberculous pleurisy may contribute to the local immune response against Mycobacterium tuberculosis infection.
Qiao D; Yang BY; Li L; Ma JJ; Zhang XL; Lao SH; Wu CY
Scand J Immunol; 2011 Apr; 73(4):330-7. PubMed ID: 21223348
[TBL] [Abstract][Full Text] [Related]
9. CD4 T Cells in
McLaughlin TA; Khayumbi J; Ongalo J; Tonui J; Campbell A; Allana S; Gurrion Ouma S; Odhiambo FH; Gandhi NR; Day CL
Front Immunol; 2020; 11():127. PubMed ID: 32117277
[No Abstract] [Full Text] [Related]
10. Study of CD27 and CCR4 Markers on Specific CD4
Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
Front Immunol; 2018; 9():3094. PubMed ID: 30687314
[TBL] [Abstract][Full Text] [Related]
11. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
Pathakumari B; Devasundaram S; Maddineni P; Raja A
Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
[TBL] [Abstract][Full Text] [Related]
12. Prediabetes is associated with the modulation of antigen-specific Th1/Tc1 and Th17/Tc17 responses in latent Mycobacterium tuberculosis infection.
Kumar NP; Moideen K; Dolla C; Kumaran P; Babu S
PLoS One; 2017; 12(5):e0178000. PubMed ID: 28558065
[TBL] [Abstract][Full Text] [Related]
13. CD4
Borgström EW; Fröberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Ängeby K; Tecleab T; Ruhwald M; Andersen P; Källenius G; Bruchfeld J
Tuberculosis (Edinb); 2020 Jul; 123():101959. PubMed ID: 32741535
[TBL] [Abstract][Full Text] [Related]
14. IL-4 subverts mycobacterial containment in
Pooran A; Davids M; Nel A; Shoko A; Blackburn J; Dheda K
Eur Respir J; 2019 Aug; 54(2):. PubMed ID: 31097521
[TBL] [Abstract][Full Text] [Related]
15. Active Tuberculosis Is Characterized by Highly Differentiated Effector Memory Th1 Cells.
Arrigucci R; Lakehal K; Vir P; Handler D; Davidow AL; Herrera R; Estrada-Guzmán JD; Bushkin Y; Tyagi S; Lardizabal AA; Gennaro ML
Front Immunol; 2018; 9():2127. PubMed ID: 30283456
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of late stage specific peptide antigens of Mycobacterium tuberculosis.
Singh M; Bhatt P; Sharma M; Varma-Basil M; Chaudhry A; Sharma S
Infect Genet Evol; 2019 Oct; 74():103930. PubMed ID: 31228643
[TBL] [Abstract][Full Text] [Related]
17. Filarial infection modulates the immune response to Mycobacterium tuberculosis through expansion of CD4+ IL-4 memory T cells.
Chatterjee S; Clark CE; Lugli E; Roederer M; Nutman TB
J Immunol; 2015 Mar; 194(6):2706-14. PubMed ID: 25667413
[TBL] [Abstract][Full Text] [Related]
18. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
[TBL] [Abstract][Full Text] [Related]
19. PD-1 Expression on
Day CL; Abrahams DA; Bunjun R; Stone L; de Kock M; Walzl G; Wilkinson RJ; Burgers WA; Hanekom WA
Front Immunol; 2018; 9():1995. PubMed ID: 30233588
[TBL] [Abstract][Full Text] [Related]
20. Added Value of Long-Term Cytokine Release Assays to Detect Mycobacterium tuberculosis Infection in HIV-Infected Subjects in Uganda.
Dirix V; Schepers K; Massinga-Loembe M; Worodria W; Colebunders R; Singh M; Locht C; Kestens L; Mascart F;
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):344-52. PubMed ID: 27306506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
